|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
1 study |
0.06% |
|
|
Communicable diseases |
1 study |
0.06% |
|
|
Disaster risk reduction and health emergencies |
1 study |
0.06% |
|
|
Violence |
1 study |
0.06% |
|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
2 studies |
0.12% |
|
|
Access to essential medical products, vaccines and technologies |
2 studies |
0.12% |
|
|
Biomedical products and engineering |
10 studies |
0.62% |
|
|
Communicable diseases |
4 studies |
0.25% |
|
|
Determinants of health |
1 study |
0.06% |
|
|
Diagnostics |
45 studies |
2.78% |
|
|
Drug discovery and development |
39 studies |
2.41% |
|
|
Emerging and re-emerging diseases |
1 study |
0.06% |
|
|
Filipino traditional and complementary medicine |
1 study |
0.06% |
|
|
Functional foods |
2 studies |
0.12% |
|
|
Genomics/Molecular Technology |
1 study |
0.06% |
|
|
Health information systems |
1 study |
0.06% |
|
|
Information and communication technologies for health |
6 studies |
0.37% |
|
|
Information and communication technology (ICT) for health |
1 study |
0.06% |
|
|
Non-communicable diseases |
1 study |
0.06% |
|
Global competitiveness and innovation in health |
Oral health |
1 study |
0.06% |
|
|
Accidents and injuries |
1 study |
0.06% |
|
|
Disaster risk reduction and health emergencies |
4 studies |
0.25% |
|
|
Emerging and re-emerging diseases |
6 studies |
0.37% |